文献速递心脑血管急症重症综合管理与镇静镇痛

时依性急性生理与慢性健康评分II对重症卒中患者死亡风险的影响及预测价值:基于MIMIC-III的数据分析

[Impact and predictive value of time-dependent acute physiology and chronic health evaluation II score on death risk in patients with severe stroke: data analysis based on MIMIC-III].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论重症卒中患者APACHE II评分每升高1分,14天全因死亡风险增加48%(HR=1.48,95%CI 1.31-1.66,P<0.001)。

该研究基于MIMIC-III数据库纳入3229例重症卒中患者,按卒中类型分为蛛网膜下腔出血(SAH)、脑出血(ICH)、缺血性卒中(IS)及其他组,记录每日APACHE II评分,以入ICU后14天全因死亡为结局,建立纵向与时间-事件数据的联合模型。控制年龄、性别、入院来源、基线SOFA评分及吸烟史后,APACHE II评分与14天全因死亡显著相关(HR=1.48,95%CI 1.31-1.66,P<0.001),即每升高1分死亡风险增加48%(95%CI 31%-66%)。亚组分析显示SAH患者中影响较大(HR=1.43,95%CI 1.10-1.85),ICH与IS组较小(HR分别为1.37和1.35);年龄>60岁与≤60岁亚组间无显著差异(HR 1.37 vs 1.35);SOFA≤3组影响大于SOFA>3组(HR 1.40 vs 1.34)。作者认为时依性APACHE II评分是评估重症卒中患者死亡风险的重要指标。

要点

  • 每1分APACHE II评分升高对应14天全因死亡风险增加48%(HR=1.48,95%CI 1.31-1.66,P<0.001)。
  • SAH患者中APACHE II评分对14天死亡风险影响较大(HR=1.43,95%CI 1.10-1.85)。
  • ICH与IS组影响相对较小,HR(95%CI)分别为1.37(1.15-1.64)和1.35(1.06-1.71)。
  • 年龄>60岁与≤60岁亚组间APACHE II评分对14天死亡风险无显著差异(HR 1.37 vs 1.35)。
  • SOFA≤3组APACHE II评分影响大于SOFA>3组(HR 1.40 vs 1.34)。

适用人群与场景

  • MIMIC-III数据库中纳入的3229例重症卒中患者,按主要卒中类型分为SAH、ICH、IS及其他组。

研究设计与关键结果

  • 研究类型为基于MIMIC-III数据库的数据分析,纳入3229例重症卒中患者,记录每日APACHE II评分,以入ICU后14天全因死亡为结局指标。
  • 包含APACHE II评分及APACHE II与年龄交互项的联合模型拟合较好。
  • APACHE II评分受年龄、性别、入院来源、基线SOFA评分和吸烟史影响。
  • 控制上述混杂因素后,APACHE II评分与14天全因死亡显著相关(HR=1.48,95%CI 1.31-1.66,P<0.001),每升高1分死亡风险增加48%(95%CI 31%-66%)。
  • 亚组分析:SAH患者HR=1.43(95%CI 1.10-1.85),ICH组HR=1.37(95%CI 1.15-1.64),IS组HR=1.35(95%CI 1.06-1.71)。
  • 年龄>60岁与≤60岁亚组HR(95%CI)分别为1.37(1.08-1.72)与1.35(1.07-1.70),无显著差异。
  • SOFA≤3组HR(95%CI)为1.40(1.16-1.70),SOFA>3组为1.34(1.16-1.55),SOFA≤3组影响较大。

证据类型、等级与局限

  • 证据类型:基于MIMIC-III数据库的数据分析(联合模型分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为时依性APACHE II评分是评估重症卒中患者死亡风险的重要指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To study the influence of time-dependent acute physiology and chronic health evaluation II (APACHE II) score on 14-day death risk in patients with severe stroke, and to provide reference for clinical diagnosis and treatment.

METHODS: Data of 3 229 patients with severe stroke were enrolled from Medical Information Mart for Intensive Care-III (MIMIC-III). According to the main types of stroke, the patients were divided into subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), ischemic stroke (IS) and other groups. According to age, patients were divided into > 60 years old and ≤ 60 years old subgroups. According to the baseline of sequential organ failure assessment (SOFA) score, they were divided into subgroups of > 3 and ≤ 3. The daily measured values of APACHE II scores in each patient were recorded. And all-cause death within 14 days after admission to intensive care unit (ICU) was used as the outcome index to obtain the survival status and survival time of patients. Joint models for longitudinal and time-to-event data were established to evaluate the effect of APACHE II score measured at multiple time points on the death risk of patients, and a subgroup analysis was performed.

RESULTS: Among the joint models, the one which include APACHE II score, and the interaction items between APACHE II and age showed the better fitting. Further analysis showed that APACHE II score was affected by age, gender, hospital admission, baseline SOFA score and smoking history. After controlling for these confounding factors, APACHE II score was significantly associated with 14-day all-cause death in patients with severe stroke [hazard ratio (HR) = 1.48, 95% confidence interval (95%CI) was 1.31-1.66, P < 0.001], which indicated that the risk of death increased by 48% (95%CI was 31%-66%) for each 1-point increase in APACHE II score. Subgroup analysis showed that for different types of severe stroke patients, APACHE II score had a greater impact on the risk of 14-day death in SAH patients (HR = 1.43, 95%CI was 1.10-1.85), but had a smaller impact on ICH and IS groups [HR (95%CI) was 1.37 (1.15-1.64) and 1.35 (1.06-1.71), respectively]. There was no significant difference in APACHE II score on the risk of 14-day death between the patients aged > 60 years old and those aged ≤ 60 years old [HR (95%CI): 1.37 (1.08-1.72) vs. 1.35 (1.07-1.70), respectively]. Compared with patients with SOFA score > 3, APACHE II score had a greater impact on the risk of 14-day death in patients with SOFA score ≤ 3 [HR (95%CI): 1.40 (1.16-1.70) vs. 1.34 (1.16-1.55)].

CONCLUSIONS: Time-dependent APACHE II score is an important indicator to evaluate the risk of death in patients with severe stroke.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Cheng Y, Chen Q, Wu S, et al. [Impact and predictive value of time-dependent acute physiology and chronic health evaluation II score on death risk in patients with severe stroke: data analysis based on MIMIC-III]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34955135. doi:10.3760/cma.j.cn121430-20210409-00533

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。